On the basis of screening hits (1a,b), a series of selective, high affinity prostacyclin receptor antagonists was developed. The optimized lead compound 25d [(4,5-dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxybenzyl)phenyl]amine] had analgesic activity in the rat.
基于筛选结果(1a,b),开发了一系列选择性,高亲和力的
前列环素受体拮抗剂。优化的
铅化合物25d [(4,5-二氢-
1H-咪唑-2-基)-[4-(4-异丙氧基苄基)苯基]胺]在大鼠中具有镇痛作用。